Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLARE: Fluorescent Probe for Assessment of Renal Elimination
NCT07643467Phase 4Recruiting
- Start
- Sep 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
A Phase 4 trial of relmapirazin in critical illness, augmented renal clearance (ARC). Started Sep 2026; status: recruiting.
02
Drugs
relmapirazin
03
Conditions
critical illnessaugmented renal clearance (ARC)
Beyond the preview
Go deeper on NCT07643467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07643467.